HighGravityData
Companies / Honeywell / Filing

Honeywell — Jul 23, 2026 release

Fiscal 2026 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000773840-26-000120
Open on SEC.gov ↗
Showing in the filing
Earnings per share of common stock from continuing operations - diluted
“$21.05 - $21.35”
Period
FY2026
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 21
Sales
“$19.8B - $20.0B”
Organic Growth
“3% - 4%”
Segment Margin
“20.1% - 20.5%”
Expansion
“Up 250 - 290 bps”
Adjusted Earnings Per Share
“$8.05 - $8.35”
Adjusted Earnings Growth
“25% - 29%”
Operating Cash Flow
“~$2.1B”
Free Cash Flow
“~$2.0B”
Sales for FY2026
“$19.8 billion to $20.0 billion”
Organic sales growth for FY2026
“3% to 4%”
Organic growth for H2 FY2026
“4% to 6%”
Organic growth, second half for H2 FY2026
“4% to 6%”
Segment margin for FY2026
“20.1% to 20.5%”
Segment margin expansion for FY2026
“250 to 290 basis points year over year”
Adjusted earnings per share for FY2026
“$8.05 to $8.35”
Operating cash flow for FY2026
“approximately $2.1 billion”
Earnings per share of common stock from cont… for FY2026
“$21.05 - $21.35”
Adjusted earnings per share of common stock … for FY2026
“$8.05 - 8.35”
Weighted average diluted shares for FY2026
“approximately 319 million”
Cash provided by operating activities from c… for FY2026
“$1.9 - $2.2”
Free cash flow for FY2026
“~1.8 - $2.1”
Exhibit 99.1 · the passage around this item
… earlier in the release
- MORE - Honeywell Technologies Q2’26 Results - 20   Twelve Months Ended December 31,   2025 2026(E) Honeywell Less: Separation Adjustments 1 Honeywell Technologies Honeywell Technologies Earnings per share of common stock from continuing operations - diluted 2 $ 13.88   $ 10.64  $ 3.24   $21.05 - $21.35 Pension income 3 (0.91) (0.78) (0.13) No Forecast Amortization of acquisition-related intangibles 4 1.34  0.14  1.20  1.10  Acquisition-related costs 5 0.11  —  0.11  0.06  Divestiture-related costs 6 1.43  0.62  0.81  No Forecast Debt restructuring costs 7 —  —  —  0.72  ERP implementation costs 8 —  —  —  0.06  Impairment of assets held for sale 9 0.65  —  0.65  0.74  Indefinite-lived intangible asset impairment 10 0.14  —  0.14  —  Impairment of goodwill 11 2.25  —  2.25  —  (Gain) loss on sale of business 12 0.09  —  0.09  (0.02) Gain related to Resideo indemnification and reimbursement agreement termination 13 (2.50) —  (2.50) —  Adjustment to estimated future environmental liabilities 14 0.50  0.43  0.07  —  Loss on settlement of divestiture of asbestos liabilities 15 0.35  —  0.35  —  Flexjet-related litigation matters 16 0.95  0.95  —  —  Impact of Russia-Ukraine conflict 17 —  —  —  0.02  Gain on deconsolidation of Quantinuum 18 —  —  —  (15.85) Equity loss of Quantinuum 19 —  —  —  No Forecast Loss on Quantinuum 20 0.18  —  0.18  0.17  Adjusted earnings per share of common stock from continuing operations - diluted $ 18.46   $ 6.46   $8.05 - 8.35 1  Includes the financia
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.